Treating 5 percent of hepatitis C patients with new drugs would cut cost, infections
Tuesday, October 6, 2015 - 12:50
in Health & Medicine
Treating 5 percent of all hepatitis C patients with the latest drugs would be more effective at reducing infections and health care costs than the current approach, a new study shows. The cost-benefits analysis by researchers from the USC Schaeffer Center for Health Policy and Economics and other institutions compares three treatment options to the […]